283 related articles for article (PubMed ID: 21280538)
21. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
[TBL] [Abstract][Full Text] [Related]
22. Localized and systemic scleroderma show different histological responses to methotrexate therapy.
Seyger MM; van den Hoogen FH; van Vlijmen-Willems IM; van de Kerkhof PC; de Jong EM
J Pathol; 2001 Apr; 193(4):511-6. PubMed ID: 11276011
[TBL] [Abstract][Full Text] [Related]
23. Topical tacrolimus in the treatment of localized scleroderma.
Mancuso G; Berdondini RM
Eur J Dermatol; 2003; 13(6):590-2. PubMed ID: 14721783
[TBL] [Abstract][Full Text] [Related]
24. Superficial morphea: 20-year follow up in a patient with concomitant psoriasis vulgaris.
Saleh Z; Arayssi T; Saleh Z; Ghosn S
J Cutan Pathol; 2009 Oct; 36(10):1105-8. PubMed ID: 19602063
[TBL] [Abstract][Full Text] [Related]
25. Treatment of genital lichen sclerosus with topical calcipotriol.
Gupta S; Saraswat A; Kumar B
Int J STD AIDS; 2005 Nov; 16(11):772-4. PubMed ID: 16303082
[No Abstract] [Full Text] [Related]
26. Topical tacrolimus 0.1% ointment in the treatment of localized scleroderma. An open label clinical and histological study.
Stefanaki C; Stefanaki K; Kontochristopoulos G; Antoniou C; Stratigos A; Nicolaidou E; Gregoriou S; Katsambas A
J Dermatol; 2008 Nov; 35(11):712-8. PubMed ID: 19120765
[TBL] [Abstract][Full Text] [Related]
27. A double-blind, randomized quantitative comparison of calcitriol ointment and calcipotriol ointment on epidermal cell populations, proliferation and differentiation.
Körver JE; Vissers WH; van Rens DW; Pasch MC; van Erp PE; Boezeman JB; van De Kerkhof PC
Br J Dermatol; 2007 Jan; 156(1):130-7. PubMed ID: 17199579
[TBL] [Abstract][Full Text] [Related]
28. Generalized morphea.
Strober BE
Dermatol Online J; 2003 Oct; 9(4):24. PubMed ID: 14594597
[TBL] [Abstract][Full Text] [Related]
29. Morphea and localized scleroderma in children.
Vierra E; Cunningham BB
Semin Cutan Med Surg; 1999 Sep; 18(3):210-25. PubMed ID: 10468041
[TBL] [Abstract][Full Text] [Related]
30. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
Bovenschen HJ; Erceg A; Van Vlijmen-Willems I; Van De Kerkhof PC; Seyger MM
J Dermatolog Treat; 2007; 18(1):32-9. PubMed ID: 17365265
[TBL] [Abstract][Full Text] [Related]
31. Localized scleroderma: a series of 52 patients.
Toledano C; Rabhi S; Kettaneh A; Fabre B; Fardet L; Tiev KP; Cabane J
Eur J Intern Med; 2009 May; 20(3):331-6. PubMed ID: 19393504
[TBL] [Abstract][Full Text] [Related]
32. Linear morphea and leg length discrepancy: treatment with a leg-lengthening procedure.
Handler MZ; Wulkan AJ; Stricker SJ; Schachner LA
Pediatr Dermatol; 2013; 30(5):616-8. PubMed ID: 23756319
[TBL] [Abstract][Full Text] [Related]
33. Grover's disease: successful treatment with acitretin and calcipotriol.
Miljković J; Marko PB
Wien Klin Wochenschr; 2004; 116 Suppl 2():81-3. PubMed ID: 15506319
[TBL] [Abstract][Full Text] [Related]
34. A Case of Bullous Morphea Resistant to Methotrexate and Phototherapy Successfully Treated With Mycophenolate Mofetil.
Cuellar-Barboza A; Alberto Cardenas-De La Garza J; Daniel Villarreal-Villarreal C; Ocampo-Candiani J; Gomez-Flores M; Welsh O; Herz-Ruelas ME
J Drugs Dermatol; 2018 Oct; 17(10):1123-1125. PubMed ID: 30365594
[TBL] [Abstract][Full Text] [Related]
35. Biopsy proven morphea treated with tacalcitol ointment: case report.
Ascari-Raccagni A; Dondas A; Dubini A; Righini MG; Trevisan G
Acta Dermatovenerol Croat; 2010; 18(4):248-51. PubMed ID: 21251440
[TBL] [Abstract][Full Text] [Related]
36. [Incapacitating pansclerotic morphea in childhood].
Ferrandiz C; Henkes J; González J; Peyri J
Med Cutan Ibero Lat Am; 1981; 9(5):377-82. PubMed ID: 7038353
[TBL] [Abstract][Full Text] [Related]
37. Correlation between soluble interleukin-2 receptor levels and modified Rodnan total skin thickness scores in a patient with generalized morphea: a case report.
Nakai N; Hotta E; Asai J; Katoh N
Allergol Int; 2013 Sep; 62(3):391-3. PubMed ID: 23880615
[No Abstract] [Full Text] [Related]
38. [Morphea associated with toxoplasmosis].
Solovăstru L; Amălinei C
Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):646-9. PubMed ID: 14756079
[TBL] [Abstract][Full Text] [Related]
39. Therapy of childhood generalized morphea: case reports and reviews of the literature of Japanese cases.
Kawashima H; Watanabe C; Kashiwagi Y; Sato S; Ioi H; Sasamoto M; Takekuma K; Ookubo Y; Ooi T; Hoshika A
Pediatr Int; 2006 Jun; 48(3):342-5. PubMed ID: 16732809
[No Abstract] [Full Text] [Related]
40. Methotrexate for sclerotic skin disorders: no evidence for effectiveness.
Jessop S; Whitelaw D
Br J Dermatol; 2009 Nov; 161(5):1205. PubMed ID: 19663873
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
